Bevacizumab as First-Line Treatment in HER2-Negative...

Tumori Journal 2016 / 09 Vol. 102; Iss. 5

Bevacizumab as First-Line Treatment in HER2-Negative Advanced Breast Cancer: Pros and Cons

Sini, Valentina, Cassano, Alessandra, Corsi, Domenico, De Laurentiis, Michele, Gamucci, Teresa, Mauri, Mariella, Naso, Giuseppe, Roselli, Mario, Maria Ruggeri, Enzo, Tonini, Giuseppe, Vici, Patrizia,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
102
Language:
english
Journal:
Tumori Journal
DOI:
10.5301/tj.5000555
Date:
September, 2016
File:
PDF, 259 KB
english, 2016
Conversion to is in progress
Conversion to is failed